Pharmacologic and nonpharmacologic therapies for stroke prevention in nonvalvular atrial fibrillation

Keyphrases

• Pharmacological Therapy 100%
• Warfarin 100%
• Non-valvular Atrial Fibrillation 100%
• Non-pharmacological Therapy 100%
• Stroke Prevention 100%
• Atrial Fibrillation 66%
• Anticoagulant Therapy 66%
• Left Atrial Appendage 66%
• Non-pharmacological Methods 66%
• Randomized Trial 33%
• Surgical Technique 33%
• Vitamin K Antagonists 33%
• Anticoagulants 33%
• Thromboembolism 33%
• Thrombus Formation 33%
• Bleeding Risk 33%
• Stroke Risk 33%
• Ischemic Stroke 33%
• Epicardial 33%
• Endovascular Techniques 33%
• Dabigatran 33%
• Stroke Prevention in Atrial Fibrillation 33%
• Preventing Stroke 33%
• Rivaroxaban 33%
• Potential Interaction 33%
• Coagulation Monitoring 33%
• Novel Pharmacotherapy 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Atrial Fibrillation 100%
• Cerebrovascular Accident 100%
• Warfarin 60%
• Anticoagulant Agent 40%
• Thrombus 20%
• Pharmacotherapy 20%
• Brain Ischemia 20%
• Thromboembolism 20%
• Dabigatran 20%
• Antivitamin K 20%
• Anticoagulation Therapy 20%
• Rivaroxaban 20%

Neuroscience

• Vitamin K Antagonist 20%